Biotii Technologies Corp. strives to genetically engineer microorganisms to produce cannabinoids identical to those found in nature while meeting the standards demanded by consumer goods and pharmaceutical industries – all at a fraction of the cost of current producers. The Biotii team is comprised of scientists trained at Harvard, MIT, Rutgers, University of Minnesota and Mayo Clinic. Team members have been awarded numerous recognitions including Forbes 30 under 30, Microsoft Prize at Hack Harvard, Intel Prize at Stanford TreeHacks, Davidson Presidential Scholarship Award, honorary doctorates and others.